LP PeptideNAD+
Ordered NAD+ from LP Peptide? Mail in a sample (US only) and let us test it.
Test my supplyLP Peptide's NAD+ record shows repeated identity failures followed by low-purity results, so the low rating reflects a persistent evidence problem rather than one bad vial. Later tests measured 94.3% with -21% fill and 86% purity.
Corporate records and storefront policies leave the seller, merchant and quality sign-off chain unattributed. Shared catalog assets, Yuan PDF links, crypto checkout and lookalike domains map a wider network than LP’s factory-direct pitch.
Unlock original COAs
View and download original lab PDFs for Finnrick tests, including LP Peptide rows.
Cancel anytime
About LP Peptide test results from Finnrick
LP Peptide is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 9 peptides and 107 tests, including ratings, observed price signals, recent test dates, and correction history where available.
Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.
The most visible LP Peptide peptides in this dataset are BPC-157 (6 tests), CJC-1295 (2 tests) and GHK-Cu (16 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.
Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 107 recent tests.
Ordered NAD+ from LP Peptide? Mail in a sample (US only) and let us test it.
Test my supply